mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.005 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.005 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.005 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |